| |
All Patients (n = 29)
|
Aspirators (n = 10)
|
Non-aspirators (n = 19)
|
p-value
|
|---|
|
Median age
|
54 (30–73)
|
54 (31–67)
|
54 (30–73)
|
0.75
|
|
Dose (cGy)
|
7000 (6400–7500)
|
7175 (7000–7500)
|
7000 (6400–7500)
|
0.11
|
| |
N (%)
|
N (%)
|
N (%)
| |
|
Sex
|
|
Male
|
23 (79.3)
|
7 (70.0)
|
16 (84.2)
|
0.63
|
|
Female
|
6 (20.7)
|
3 (30.0)
|
3 (15.8)
| |
|
Smoking
|
|
No
|
23 (79.3)
|
6 (60.0)
|
17 (89.5)
|
0.14
|
|
Yes
|
6 (20.7)
|
4 (40.0)
|
2 (10.5)
| |
|
Tumor Site
|
|
Oropharynx
|
22 (75.9)
|
9 (90.0)
|
13 (68.4)
|
0.065
|
|
Unknown Primary
|
6 (20.7)
|
0
|
6 (31.6)
| |
|
Hypopharynx
|
1 (3.5)
|
1 (10.0)
|
0
| |
|
T stage
|
|
T0
|
5 (17.2)
|
0
|
5 (26.3)
|
0.18
|
|
T1
|
8 (27.6)
|
3 (30.0)
|
5 (26.3)
| |
|
T2
|
11 (37.9)
|
4 (40.0)
|
7 (36.8)
| |
|
T3
|
4 (13.8)
|
3 (30.0)
|
1 (5.3)
| |
|
T4
|
1 (3.5)
|
0
|
1 (5.3)
| |
|
N stage
|
|
N1
|
1 (3.5)
|
0
|
1 (5.3)
|
0.17
|
|
N2a
|
3 (10.3)
|
0
|
3 (15.8)
| |
|
N2b
|
21 (72.4)
|
7 (70.0)
|
14 (73.7)
| |
|
N2c
|
4 (13.8)
|
3 (30.0)
|
1 (5.3)
| |
|
Stage
|
|
III
|
2 (6.9)
|
1 (10.0)
|
1 (5.3)
|
0.42
|
|
IVA
|
26 (89.6)
|
8 (80.0)
|
18 (94.7)
| |
|
IVB
|
1 (3.5)
|
1 (10.0)
|
0
| |
|
Grade
|
|
1
|
1 (3.5)
|
0
|
1 (5.3)
|
0.44
|
|
2
|
9 (31.0)
|
5 (50.0)
|
4 (21.1)
| |
|
3
|
9 (31.0)
|
2 (20.0)
|
7 (36.8)
| |
|
Unknown
|
10 (34.5)
|
3 (30.0)
|
7 (36.8)
| |
|
p16 status
|
|
Positive
|
14 (48.3)
|
3 (30.0)
|
11 (57.9)
|
0.99
|
|
Negative
|
1 (3.4)
|
0
|
1 (5.3)
| |
|
Unknown
|
14 (48.3)
|
7 (70.0)
|
7 (36.8)
| |
